论文部分内容阅读
肝转移癌患者绝大多数已失去手术切除机会,临床上预后较差。为了提高对肝转移癌的治疗效果,探索综合治疗的有效方法。1994年以来,我院在采取肝动脉灌注化疗的同时合并使用中药肝复乐常规给药2个月治疗肝转移癌42例,收到满意效果,现报告如下。1 临床资料患者共42例,男28例,女14例,男女之比为2:1;年龄31～72岁,平均48岁;其中大肠癌肝转移14例,乳腺癌肝转移7例,胃癌肝转移9例,肺癌肝转移8例,卵巢癌肝转移4例。全组病例均系原发灶已切除后1～7年内出现肝转移,原发病灶诊断均经病理切片证实。肝转移灶经B超、CT及肝血管造影、肝上照像AFD检查诊断。随机分为治疗组与对照组。
The vast majority of patients with liver metastases have lost surgical resection opportunities and have poor clinical outcomes. In order to improve the therapeutic effect on liver metastases, an effective method for comprehensive treatment is explored. Since 1994, our hospital has taken hepatic arterial infusion chemotherapy and concurrently used traditional Chinese medicine Ganfule for 2 months for the treatment of 42 cases of liver metastases, and has received satisfactory results. The report is as follows. A total of 42 patients with clinical data, 28 males and 14 females, male to female ratio of 2:1; aged 31 to 72 years, mean 48 years; including 14 cases of colorectal liver metastases, 7 cases of breast cancer liver metastases, gastric cancer There were 9 cases of liver metastases, 8 cases of liver metastases from lung cancer, and 4 cases of liver metastases from ovarian cancer. All cases were hepatic metastases within 1 to 7 years after primary lesions had been removed. The primary lesions were confirmed by pathological sections. Liver metastases were diagnosed by B-ultrasound, CT, hepatic angiography, and liver photogrammetry. Randomly divided into treatment group and control group.